semaglutide glp 1 receptor agonist PDB-101: Molecule of the Month: GLP-1 Agonists Semaglutide vs. Tirzepatide: Which GLP-1

Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats

31 Over the past 20 years, new GLP-1RAs with extended half-lives have proven to be highly effective treatments for T2D and even weight loss

These findings suggest that it is possible to increase GLP-1 secretion and manage T2DM and its complications by restoring and improving the gut microbiota [158]

16,20 GLP-1 analogues, especially those that are fatty acidacylated (liraglutide and semaglutide), have a tendency to form oligomers that can influence absorption

Interestingly, a new version of GLP-1s known as tirzepatide (Mounjaro) may be more effective than semaglutide

Lemen, Y